Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance

Detecting and targetting oncogenic fusion proteins in the genomic era

(2015) Monika A. Davare et al.   BIOLOGY OF THE CELL

c-Met Overexpression Contributes to the Acquired Apoptotic Resistance of Nonadherent Ovarian Cancer Cells through a Cross Talk Mediated by Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase 1/2

(2015) Maggie K.S. Tang et al.   NEOPLASIA

Genomic profile of ovarian carcinomas

(2014) Francesca Micci et al.   BMC CANCER

HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer

(2014) Blanca Ortiz-Muñoz et al.   TUMOR BIOLOGY

SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

(2013) Raul Aguirre-Gamboa et al.   PLoS One

Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer

(2013) Jun-Jun Qiu et al.   TUMOR BIOLOGY

Expression and prognostic significance of centromere protein A in human lung adenocarcinoma

(2012) Qing Wu et al.   LUNG CANCER

An inverse relationship to germline transcription defines centromeric chromatin in C. elegans

(2012) Reto Gassmann et al.   NATURE

Elevated human epididymis protein 4 concentrations in chronic kidney disease

(2012) B. Nagy et al.   ANNALS OF CLINICAL BIOCHEMISTRY

The ABCs of CENPs

(2011) Marinela Perpelescu et al.   CHROMOSOMA

Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases

(2011) Yongjung Park et al.   CLINICAL BIOCHEMISTRY

Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases

(2011) J. M. Escudero et al.   CLINICAL CHEMISTRY

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

(2011) E S Ratner et al.   ONCOGENE

ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth

(2011) Yongmei Li et al.   PLoS One

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass

(2010) Brian Nolen et al.   GYNECOLOGIC ONCOLOGY

A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

(2009) Samuel C. Mok et al.   CANCER CELL

Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival

(2009) Mads Thomassen et al.   GENES CHROMOSOMES & CANCER

The CENP-S complex is essential for the stable assembly of outer kinetochore structure

(2009) Miho Amano et al.   JOURNAL OF CELL BIOLOGY

CENPA overexpression promotes genome instability in pRb-depleted human cells

(2009) Angela Amato et al.   Molecular Cancer

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

Centromeres in cell division, evolution, nuclear organization and disease

(2008) Amanda Gonçalves dos Santos Silva et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure

(2007) W.H. Wilson Tang et al.   CLINICAL BIOCHEMISTRY

CENP-O Class Proteins Form a Stable Complex and Are Required for Proper Kinetochore Function

(2007) Tetsuya Hori et al.   MOLECULAR BIOLOGY OF THE CELL